|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guan JL: Integrin signaling through FAK in
the regulation of mammary stem cells and breast cancer. IUBMB Life.
62:268–276. 2010.PubMed/NCBI
|
|
4
|
Yun SP, Ryu JM and Han HJ: Involvement of
β1-integrin via PIP complex and FAK/paxillin in
dexamethasone-induced human mesenchymal stem cells migration. J
Cell Physiol. 226:683–692. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li D, Ding J, Wang X, Wang C and Wu T:
Fibronectin promotes tyrosine phosphorylation of paxillin and cell
invasiveness in the gastric cancer cell line AGS. Tumori.
95:769–779. 2009.PubMed/NCBI
|
|
6
|
Missan DS, Mitchell K, Subbaram S and
DiPersio CM: Integrin α3β1 signaling through MEK/ERK determines
alternative polyadenylation of the MMP-9 mRNA transcript in
immortalized mouse keratinocytes. PLoS One. 10:e01195392015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pickarski M, Gleason A, Bednar B and Duong
LT: Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma
metastasis. Oncol Rep. 33:2737–2745. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Osório-Costa F, Rocha GZ, Dias MM and
Carvalheira JB: Epidemiological and molecular mechanisms aspects
linking obesity and cancer. Arq Bras Endocrinol Metabol.
53:213–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Neil E and Kolch W: Conferring
apccificity on the ubiquitous Ras/MEK signaling pathway. Br J
Cancer. 90:283–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steelman LS, Abrams SL, Whelan J, Bertrand
FE, Ludwig DE, Bäsecke J, Libra M, Stivala F, Milella M, Tafuri A,
et al: Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and
Jak/STAT pathways to leukemia. Leukemia. 22:686–707. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheung KL, Lee JH, Shu L, Kim JH, Sacks DB
and Kong AN: The Ras GTPase-activating-like protein IQGAPI mediates
Nrf2 protein activation via the mitogen-activated protein
kinase/extracellular signal regulated kinase (ERK) kinase (MEK)-ERK
pathway. J Biol Chem. 288:22378–22386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bai Y, Cui W, Xin Y, Miao X, Barati MT,
Zhang C, Chen Q, Tan Y, Cui T, Zheng Y and Cai L: Prevention by
sulforaphane of diabetic cardiomyopathy is associated with
up-regulation of Nrf2 expression transcription activation. J Mol
Cell Cardiol. 57:82–95. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Muslin AJ: MAPK signalling in
cardiovascular health and disease: Molecular mechanisms and
therapeutic targets. Clin Sci (Lond). 115:203–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guruvayoorappan C and Kuttan G:
Amentoflavone inhibits experimental tumor metastasis through a
regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase,
lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and cytokines in
lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol.
30:711–727. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Kuiatse I, Lee AV, Pan J, Giuliano
A and Cui X: Sustained c-Jun-NH2-kinase activity promotes
epithelial mesenchymal transition, invasion, and survival of breast
cancer cells by regulating extracellular signal-regulated kinase
activation. Mol Cancer Res. 8:266–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chatziioannou AF: PET scanners dedicated
to molecular imaging of small animal models. Mol Imaging Biol.
4:47–63. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kosugi C, Saito N, Murakami K, Ochiai A,
Koda K, Ono M, Sugito M, Ito M, Oda K, Seike K and Miyazaki M:
Positron emission tomography for preoperative staging in patients
with locally advanced or metastatic colorectal adenocarcinoma in
lymphnode metastasis. Hepatogastroentero logy. 55:398–402.
2008.
|
|
18
|
Nahas CS, Akhurst T, Yeung H, Leibold T,
Riedel E, Markowitz AJ, Minsky BD, Paty PB, Weiser MR, Temple LK,
et al: Positron emission tomography detection of distant metastatic
or synchronous disease in patients with locally advanced rectal
cancer receiving preoperative chemoradiation. Ann Surg Oncol.
15:704–711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meerovitch K, Bergeron F, Leblond L,
Grouix B, Poirier C, Bubenik M, Chan L, Gourdeau H, Bowlin T and
Attardo G: A novel RGD antagonist that targets both alphavbeta3 and
alpha5beta1 induces apoptosis of angiogenic endothelial cells on
type I collagen. Vascul Pharmacol. 40:77–89. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jianliang You, Liuyong Zhou and Ming Xu:
Clinical research of the treatment of advanced gastric cancer using
Chinese herbal medicine WD-3. Hubei J Traditional Chinese Med.
26:8–9. 2004.
|
|
21
|
Zhou LY, Shan ZZ and You JL: Clinical
observation on treatment of colonic cancer with combined treatment
of chemotherapy and chinese herbal medicine. Chin J Integr Med.
15:107–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Watanabe H, Kanzaki H, Narukawa S, Inoue
T, Katsuragawa H, Kaneko Y and Mori T: Bcl 2 and Fas expression in
eutopic and ectopic human endometrium during the menstrual cycle in
relation to endometrial cell apoptosis. Am J Obstet Gynecol.
176:360–368. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zehorai E, Yao Z, Plotnikov A and Seger R:
The subcellular localization of MEK and ERK-a novel nuclear
translocation signal (NTS) paves a way to the nucleus. Mol Cell
Endocrinol. 314:213–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sasaki Y, Nishina T, Yasui H, Goto M, Muro
K, Tsuji A, Koizumi W, Toh Y, Hara T and Miyata Y: Phase II trial
of nanoparticle albumin-bound paclitaxel as second-line
chemotherapy for unresectable or recurrent gastric cancer. Cancer
Sci. 105:812–817. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Böger C, Warneke VS, Behrens HM, Kalthoff
H, Goodman SL, Becker T and Röcken C: Integrins αvβ3 and αvβ5 as
prognostic, diagnostic, and therapeutic targets in gastric cancer.
Gastric Cancer. 18:784–795. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Friedland JC, Lee MH and Boettiger D:
Mechanically activated integrin switch controls alpha5beta1
function. Science. 323:642–644. 2009. View Article : Google Scholar : PubMed/NCBI
|
